human simcyp simulator version 23 Search Results


simcyp population based adme simulator  (Simcyp)
86
Simcyp simcyp population based adme simulator
Simcyp Population Based Adme Simulator, supplied by Simcyp, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+simcyp+simulator+version+23/adme+based+population+simcyp+simulator/pmc13148688-89-0-0
Average 86 stars, based on 1 article reviews
simcyp population based adme simulator - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
cloe® predict  (Cyprotex Discovery)
90
Cyprotex Discovery cloe® predict
Cloe® Predict, supplied by Cyprotex Discovery, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+simcyp+simulator+version+23/cloe+pk/10__3390_slash_molecules24071295-84-22-24
Average 90 stars, based on 1 article reviews
cloe® predict - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
pbpk  (Simcyp)
86
Simcyp pbpk
Pbpk, supplied by Simcyp, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+simcyp+simulator+version+23/pbpk/pmc13136160-19-3-4
Average 86 stars, based on 1 article reviews
pbpk - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
marvinsketch 18.30.0  (ChemAxon LLC)
90
ChemAxon LLC marvinsketch 18.30.0
Physicochemical properties, blood binding and ADME parameters of BPA.
Marvinsketch 18.30.0, supplied by ChemAxon LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+simcyp+simulator+version+23/marvinsketch+software/pmc10120294-5-25-28
Average 90 stars, based on 1 article reviews
marvinsketch 18.30.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
oncology innovative medicines dmpk  (AstraZeneca ltd)
90
AstraZeneca ltd oncology innovative medicines dmpk
Physicochemical properties, blood binding and ADME parameters of BPA.
Oncology Innovative Medicines Dmpk, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+simcyp+simulator+version+23/dmpk+innovative+medicines/pmc05256607-62-202-210
Average 90 stars, based on 1 article reviews
oncology innovative medicines dmpk - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
nexera series  (Shimadzu Corporation)
99
Shimadzu Corporation nexera series
Physicochemical properties, blood binding and ADME parameters of BPA.
Nexera Series, supplied by Shimadzu Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+simcyp+simulator+version+23/Nexera+Series/custom%40228-65002-58%4025048637
Average 99 stars, based on 1 article reviews
nexera series - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

Image Search Results


Physicochemical properties, blood binding and ADME parameters of BPA.

Journal: Data in Brief

Article Title: Data on ADME parameters of bisphenol A and its metabolites for use in physiologically based pharmacokinetic modelling

doi: 10.1016/j.dib.2023.109101

Figure Lengend Snippet: Physicochemical properties, blood binding and ADME parameters of BPA.

Article Snippet: Description of data collection , Data on compounds’ physicochemical and ADME properties were collected from published articles, reports, databases (Pubchem) and web documents, calculated in MarvinSketch 18.30.0 ( http://www.chemaxon.com ), or were predicted by the use of Simcyp built-in QSAR models. Primary (i.e., raw) data involving simulated data on blood concentrations and cumulative urinary excretions were predicted using Simcyp® Simulator V21. Secondary data involving experimental toxicokinetic data for PBPK model verification were obtained from available literature sources..

Techniques: Binding Assay, Recombinant

Physicochemical properties, blood and ADME parameters of BPAG and BPAS.

Journal: Data in Brief

Article Title: Data on ADME parameters of bisphenol A and its metabolites for use in physiologically based pharmacokinetic modelling

doi: 10.1016/j.dib.2023.109101

Figure Lengend Snippet: Physicochemical properties, blood and ADME parameters of BPAG and BPAS.

Article Snippet: Description of data collection , Data on compounds’ physicochemical and ADME properties were collected from published articles, reports, databases (Pubchem) and web documents, calculated in MarvinSketch 18.30.0 ( http://www.chemaxon.com ), or were predicted by the use of Simcyp built-in QSAR models. Primary (i.e., raw) data involving simulated data on blood concentrations and cumulative urinary excretions were predicted using Simcyp® Simulator V21. Secondary data involving experimental toxicokinetic data for PBPK model verification were obtained from available literature sources..

Techniques: Binding Assay

Journal: Data in Brief

Article Title: Data on ADME parameters of bisphenol A and its metabolites for use in physiologically based pharmacokinetic modelling

doi: 10.1016/j.dib.2023.109101

Figure Lengend Snippet:

Article Snippet: Description of data collection , Data on compounds’ physicochemical and ADME properties were collected from published articles, reports, databases (Pubchem) and web documents, calculated in MarvinSketch 18.30.0 ( http://www.chemaxon.com ), or were predicted by the use of Simcyp built-in QSAR models. Primary (i.e., raw) data involving simulated data on blood concentrations and cumulative urinary excretions were predicted using Simcyp® Simulator V21. Secondary data involving experimental toxicokinetic data for PBPK model verification were obtained from available literature sources..

Techniques: Mutagenesis, Drug discovery